| Literature DB >> 23840727 |
Hongtao Dong1, Qiuming Li, Ying Zhang, Wei Tan, Zhengxuan Jiang.
Abstract
PURPOSE: The interleukin-23 receptor (IL-23R) has been shown to be associated with ankylosing spondylitis (AS) in many different populations. This study examined whether IL-23R polymorphisms were associated with susceptibility to this disease in a Chinese Han population.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23840727 PMCID: PMC3696065 DOI: 10.1371/journal.pone.0067505
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical features of the investigated AS patients and controls.
| Clinical features | AS patients | Healthy controls | ||
| Total ( | % | Total ( | % | |
| Age at onset(years±S.D) | 34.6±8.2 | 37.9±8.4 | ||
| Male | 165 | 56.7 | 169 | 54.2 |
| Female | 126 | 43.3 | 143 | 45.8 |
| HLA-B27 | 216 | 69.2 | 58 | 16.0 |
| Uveitis | 163 | 56.3 | 0 | |
| Arthritis | 291 | 100 | 0 | |
Primers and restriction enzymes used for RFLP analysis of the IL23R gene.
| SNP | Primers | Restriction enzyme |
| rs7517847 |
| ECO147I |
|
| ||
| rs11209032 |
| XSPI |
|
| ||
| rs17375018 |
| BSURI |
|
|
Frequencies of alleles and genotypes of IL23R polymorphisms in AS patients and controls.
| SNP | Genotype | AS | Controls | χ2 |
|
| OR |
| Allele | ( | ( | value | (95% CI) | |||
| rs17375018 | AA | 18(6.2%) | 26(8.3%) | 1.027 | 0.311 | NS | 0.73(0.39–1.35) |
| AG | 108(37.1%) | 136(43.6%) | 2.621 | 0.105 | NS | 0.76(0.55–1.06) | |
| GG | 165(56.7%) | 150(48.1%) | 4. 488 | 0.034 | NS | 1.41(1.03–1.95) | |
| A | 144(24.7%) | 188(30.1%) | 4.379 | 0.036 | NS | 0.76(0.59–0.98) | |
| G | 438(75.3%) | 436(69.9%) | 4.379 | 0.036 | NS | 1.31(1.02–1.69) | |
| rs7517847 | TT | 104(35.7%) | 98(31.4%) | 1.266 | 0.260 | NS | 1.21(0.87–1.70) |
| GT | 146(50.2%) | 153(49.0%) | 0.077 | 0.781 | NS | 1.05(0.76–1.44) | |
| GG | 41(14.1%) | 61(19.6%) | 3.196 | 0.074 | NS | 0.68(0.44–1.04) | |
| G | 228(39.2%) | 275(44.1%) | 2.968 | 0.085 | NS | 0.82(0.65–1.03) | |
| T | 354(60.8%) | 349(55.9%) | 2.968 | 0.085 | NS | 1.22 (0.97–1.54) | |
| rs11209032 | GG | 53(18.2%) | 59(18.9%) | 0.048 | 0.826 | NS | 0.96(0.63–1.44) |
| AG | 150(51.5%) | 167(53.5%) | 0.237 | 0.627 | NS | 0.92(0.67–1.27) | |
| AA | 88(30.3%) | 86(27.6%) | 0.525 | 0.469 | NS | 1.14(0.80–1.62) | |
| A | 326 (56.0%) | 339(54.3%) | 0.346 | 0.556 | NS | 1.07(0.85–1.34) | |
| G | 256(44.0%) | 285(45.7%) | 0.346 | 0.556 | NS | 0.93(0.74–1.17) |
OR = odds ratio; 95% CI = 95% confidence interval; pc = Bonferroni corrected P; NS = not significant.
Frequencies of alleles and genotypes of IL23R polymorphism in HLA-B27-positive AS patients and controls.
| SNP | Genotype |
|
| χ2 |
|
| OR | |
| Allele | Patients | controls | value | (95%CI) | ||||
| rs17375018 | AA | 14(6.5%) | 8(13.8%) | 3.310 | 0.069 | NS | 0.43(0.17–1.09) | |
| AG | 71(32.9%) | 27(46.6%) | 3.725 | 0.054 | NS | 0.56(0.31–1.01) | ||
| GG | 131(60.6%) | 23(39.7%) | 8.186 | 0.004 | 0.024 | 2.35(1.30–4.24) | ||
| A | 99(22.9%) | 43(37.1%) | 9.540 | 0.002 | 0.006 | 0.51(0.33–0.78) | ||
| G | 333(77.1%) | 73(62.9%) | 9.540 | 0.002 | 0.006 | 1.98(1.28–3.07) | ||
| rs7517847 | TT | 81(37.5%) | 22(37.9%) | 0.004 | 0.952 | NS | 0.98(0.54–1.79) | |
| GT | 105(48.6%) | 30(51.7%) | 0.177 | 0.674 | NS | 0.88(0.49–1.58) | ||
| GG | 30(13.9%) | 6(10.3%) | 0.503 | 0.478 | NS | 1.40(0.55–3.54) | ||
| G | 165(38.2%) | 42(36.2%) | 0.154 | 0.695 | NS | 1.09(0.71–1.67) | ||
| T | 267(61.8%) | 74(63.8%) | 0.154 | 0.695 | NS | 0.92 (0.60–1.41) | ||
| rs11209032 | GG | 34(15.7%) | 11(18.9%) | 0.346 | 0.556 | NS | 0.80(0.38–1.69) | |
| AG | 124(57.4%) | 32(55.2%) | 0.093 | 0.760 | NS | 1.10(0.61–1.96) | ||
| AA | 58(26.9%) | 15(25.9%) | 0.023 | 0.880 | NS | 1.05(0.54–2.04) | ||
| A | 240(55.6%) | 62(53.4%) | 0.164 | 0.685 | NS | 1.09(0.72–1.64) | ||
| G | 192(44.4%) | 54(46.6%) | 0.164 | 0.685 | NS | 0.92(0.61–1.39) | ||
OR = odds ratio; 95% CI = 95% confidence interval;
p c = Bonferroni corrected P; NS = not significant.
Frequencies of alleles and genotypes of IL23R polymorphism in AS patients with uveitis, without uveitis, and controls.
| SNP | Genotype | AS patients | Controls |
| |
| allele | withuveitis | withoutuveitis | |||
| rs17375018 | AA | 10(6.1%) | 8(6.3%) | 26(8.3%) | |
| AG | 52(31.9%) | 56(43.7%) | 136(43.6%) | ||
| GG | 101(61.0%) | 64(50.0%) | 150(48.1%) | 0.024 | |
| A | 72(22.1%) | 72(28.1%) | 188(30.1%) | ||
| G | 254(77.9%) | 184(71.9%) | 436(69.9%) | 0.024 | |
| rs7517847 | TT | 62(38.0%) | 42(32.8%) | 98(31.4%) | |
| GT | 77(47.2%) | 69(53.9%) | 153(49.0%) | ||
| GG | 24(14.7%) | 17(13.3%) | 61(19.6%) | ||
| G | 125(39.2%) | 103(40.2%) | 275(44.1%) | ||
| T | 201(60.8%) | 153(59.8%) | 349(55.9%) | ||
| rs11209032 | GG | 32(19.6%) | 21(16.4%) | 59(18.9%) | |
| AG | 81(49.7%) | 69(53.9%) | 167(53.5%) | ||
| AA | 50(30.7%) | 38(29.7%) | 86(27.6%) | ||
| A | 181 (55.5%) | 145(56.6%) | 339(54.3%) | ||
| G | 145(44.5%) | 111(43.4%) | 285(45.7%) | ||
p c, AS patients with uveitis vs. healthy controls; p c = Bonferroni corrected P.